SBP Mrv0541 02231216432D 13 13 0 0 0 0 999 V2000 -1.9781 0.2483 0.0000 B 0 0 0 0 0 0 0 0 0 0 0 0 -1.2636 0.6608 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.0644 -0.5722 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.7318 0.5839 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.8714 -0.7438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2839 -0.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5490 0.2483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1655 0.6608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8800 0.2483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5945 0.6608 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.3091 0.2483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0235 0.6608 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 2.3091 -0.5767 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 1 0 0 0 0 1 4 1 0 0 0 0 2 7 1 0 0 0 0 3 5 1 0 0 0 0 4 6 1 0 0 0 0 5 6 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 2 0 0 0 0 11 13 1 0 0 0 0 M CHG 1 12 1 M END > DB03129 > drugbank > NC(=[NH2+])NCCCOB1OCCO1 > InChI=1S/C6H14BN3O3/c8-6(9)10-2-1-3-11-7-12-4-5-13-7/h1-5H2,(H4,8,9,10)/p+1 > InChIKey=QHANCKHXGBJANE-UHFFFAOYSA-O > 5 > 20.56757005064917 > 1 > 3 > 188.120646827 > 1 > C6H15BN3O3 > 1 > [amino({[3-(1,3,2-dioxaborolan-2-yloxy)propyl]amino})methylidene]azanium > -0.75 > 0.9905000000000005 > -0.78 > 188.013 > 0 > 1 > 1 > 12.167424307829858 > 91.33 > 53.5015 > 5 > 1 > 3.73e+01 g/l > [amino({[3-(1,3,2-dioxaborolan-2-yloxy)propyl]amino})methylidene]azanium > 0 > DB03129 > experimental > [3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine $$$$